Jamaica vs Sur: Previously treated cases tested for RR-/MDR-TB
Jamaica
100.0%
in 2023
Sur
62.0%
in 2024
Jamaica rank
1st
Sur rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Jamaica
- Sur
How they compare
Jamaica currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Jamaica's figure about 1.6 times Sur's.
The two have swapped places 9 times across 11 shared years of data; in 2005 it was Jamaica ahead.
Jamaica ranks 1st and Sur ranks 2nd of 180 countries.
Sur has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Jamaica | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.0% | 21.5% | 1.5% | Sur |
| 2010s | 45.9% | 48.1% | 2.2% | Sur |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Jamaica or Sur?
- Jamaica, at 100.0% against 62.0% in Sur as of 2023.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Jamaica and Sur?
- 38.0%, with Jamaica ahead.
- How many years of comparable data are there for Jamaica and Sur?
- 11 years are reported by both, from 2005 to 2023.
- How do Jamaica and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Jamaica ranks 1st and Sur ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.